Multinational pharmaceutical companies are dominating the OTC market followed by the prescription drug market

The landscape of OTC market is changing. Multinational pharmaceutical companies, characterized by prescription drugs, are achieving satisfactory results by actively promoting OTC products.

Menarini Korea’s ‘Fulcare,’ an antifungal treatment, Oxy Reckitt Benckiser’s Gaviscon, a treatment for gastroesophageal reflux disease and Kowa Korea’s ‘Cabagin,’ a digestive medicine are typical examples.